Veracyte revenue was $120.37 m in FY, 2019 which is a (30.8%) year over year increase from the previous period.
Veracyte revenue breakdown by business segment: 89.2% from Testing Revenue, 6.7% from Biopharmaceutical Revenue and 4.1% from Other
|FY, 2019||FY, 2018|
|Testing Revenue||$107.36 m||$91.06 m|
|Biopharmaceutical Revenue||$8.09 m||$950 k|
|Product Revenue||$923 k|
|Collaboration Revenue||$4 m|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.